COMP <GO>
HLIO vs PRLB // ALTMAN Z-SCORE & DEBT/EQUITY
Helios Technologies Inc. (NYSE) VS. Proto Labs Inc. (NYSE) • 15-METRIC TALLY: HLIO 10
— PRLB 2
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: PRLB
LAST: $66.15 (-3.09%) • MKT CAP: $2.25B
balance-sheet
3.73
LAST: $68.89 (-11.27%) • MKT CAP: $1.86B
balance-sheet
13.96
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HLIO VS. PRLB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HLIO | PRLB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.30% | 44.50% | -12.20 | PRLB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.70% | 3.50% | +1.20 | HLIO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 28.3x | 46.3x | -18.00 | HLIO | /valuation <GO> |
| Free Cash Flow Yield | 4.60% | 3.21% | +1.39 | HLIO | /fcf-yield <GO> |
| Operating Margin | 7.90% | 4.70% | +3.20 | HLIO | /operating-margins <GO> |
| Net Profit Margin | 5.80% | 4.00% | +1.80 | HLIO | /net-margins <GO> |
| Revenue Growth (YoY) | 4.10% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.53% | 0.00% | +0.53 | HLIO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 3.73 | 13.96 | -10.23 | PRLB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | HLIO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.1 | 40.7 | +8.40 | HLIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 43.2x | 81.3x | -38.10 | HLIO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.25B | $1.86B | $395.3M | HLIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HLIO REV | PRLB REV | HLIO GROSS % | PRLB GROSS % | HLIO FCF | PRLB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $839.0M | $533.1M | 32.3% | 44.5% | $103.6M | $59.7M |
| FY 2024 | $805.9M | $500.9M | 31.3% | 44.6% | $95.1M | $68.7M |
| FY 2023 | $835.6M | $0 | — | — | $83.9M | $73.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HLIO // BETA —
PRLB // BETA —